Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1994 1
1999 1
2000 4
2010 1
2011 1
2016 1
2017 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
A Next-Generation TRK Kinase Inhibitor Overcomes Acquired Resistance to Prior TRK Kinase Inhibition in Patients with TRK Fusion-Positive Solid Tumors.
Drilon A, Nagasubramanian R, Blake JF, Ku N, Tuch BB, Ebata K, Smith S, Lauriault V, Kolakowski GR, Brandhuber BJ, Larsen PD, Bouhana KS, Winski SL, Hamor R, Wu WI, Parker A, Morales TH, Sullivan FX, DeWolf WE, Wollenberg LA, Gordon PR, Douglas-Lindsay DN, Scaltriti M, Benayed R, Raj S, Hanusch B, Schram AM, Jonsson P, Berger MF, Hechtman JF, Taylor BS, Andrews S, Rothenberg SM, Hyman DM. Drilon A, et al. Among authors: bouhana ks. Cancer Discov. 2017 Sep;7(9):963-972. doi: 10.1158/2159-8290.CD-17-0507. Epub 2017 Jun 3. Cancer Discov. 2017. PMID: 28578312 Free PMC article. Clinical Trial.
Pharmacokinetics of an antiangiogenic ribozyme (ANGIOZYME) in the mouse.
Sandberg JA, Bouhana KS, Gallegos AM, Agrawal AB, Grimm SL, Wincott FE, Reynolds MA, Pavco PA, Parry TJ. Sandberg JA, et al. Among authors: bouhana ks. Antisense Nucleic Acid Drug Dev. 1999 Jun;9(3):271-7. doi: 10.1089/oli.1.1999.9.271. Antisense Nucleic Acid Drug Dev. 1999. PMID: 10435752
Sustained blockade of neurotrophin receptors TrkA, TrkB and TrkC reduces non-malignant skeletal pain but not the maintenance of sensory and sympathetic nerve fibers.
Ghilardi JR, Freeman KT, Jimenez-Andrade JM, Mantyh WG, Bloom AP, Bouhana KS, Trollinger D, Winkler J, Lee P, Andrews SW, Kuskowski MA, Mantyh PW. Ghilardi JR, et al. Among authors: bouhana ks. Bone. 2011 Feb;48(2):389-98. doi: 10.1016/j.bone.2010.09.019. Epub 2010 Sep 18. Bone. 2011. PMID: 20854944 Free PMC article.
Ribozymes as tools for therapeutic target validation in arthritis.
Jarvis TC, Bouhana KS, Lesch ME, Brown SA, Parry TJ, Schrier DJ, Hunt SW 3rd, Pavco PA, Flory CM. Jarvis TC, et al. Among authors: bouhana ks. J Immunol. 2000 Jul 1;165(1):493-8. doi: 10.4049/jimmunol.165.1.493. J Immunol. 2000. PMID: 10861088 Free article.